Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $109.7900 (-3.54%) ($109.7000 - $114.9500) on Tue. Jul. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.49% (three month average) | RSI | 50 | Latest Price | $109.7900(-3.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.745% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) IYT(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.745% (StdDev 3.49%) | Hourly BBV | 0 () | Intraday Trend | -3.2% | | | |
|
1 - 5 Day Possible Target | $106.75(-2.77%) | Resistance Level | $112.94 | 5 Day Moving Average | $111.8(-1.8%) | 10 Day Moving Average | $112.28(-2.22%) | 20 Day Moving Average | $112.94(-2.79%) | To recent high | -11.2% | To recent low | 40.3% | Market Cap | $1.764b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |